Medicinal product name Rixathon
Biosimilar medicine
Pharmaceutical form Concentrate for solution for infusion
Strength 100 mg 
Information from the MAH on shortages No information on expected shortages
Availability of medicinal product
Product No.Package sizeWholesalers' stock state
EU/1/17/1185/001 KZSRN2 Is available
Legal status Rx Prescription (Pr.II stac.)
KZSR Reimbursed medicines reference product
Summary of product characteristics, package leaflet and labeling text  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
Risk minimisation measuresIzglītojošie materiāli ārstam Izglītojošie materiāli ārstam
Izglītojošie materiāli pacientam Izglītojošie materiāli pacientam
ATC code L01FA01 Antineoplastic agents

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Is available (according to the information provided by wholesalers)
(410 containers)
Tamro, Recipe Plus, Magnum Medical, Saules aptieka, Oribalt Rīga N2
(100 mg/10 ml)
Glass vial 418.50 
KZSR*
EU/1/17/1185/001  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.

Registration information

Marketing authorisation No. EU/1/17/1185/001
Date of authorisation Jun 15, 2017
Marketing authorisation holder, country Sandoz GmbH, Austria